Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Kedudukan dalam Saham #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Harga Saham
$29.86
Disegerakkan terakhir: 2026-08-19
Modal Pasaran
$2.48B
Perubahan (1 hari)
4.92%
Perubahan (1 tahun)
502.82%
Negara
TW
Perdagangan Lin BioScience, Inc. (6696)

Kategori

Sejarah harga saham bagi Lin BioScience, Inc. (6696)
Harga penutupan tertinggi: $26.88 pada 2026-08-01

Harga penutupan terendah: $1.30 pada 2018-10-01
Sejarah harga saham Lin BioScience, Inc. dari 2018 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$542.12 39.33%
US
$1.05K 48.37%
NL
$122.63 -12.65%
AU
$144.26 474.74%
US
$762.13 6.76%
CH